Skip to main content

Table 2 Characteristics of the IV and oral clarithromycin groups after propensity matching

From: Oral versus intravenous clarithromycin in moderate to severe community-acquired pneumonia: an observational study

Characteristics IV macrolide Oral macrolide p-value
N 226 226  
Age 71 (59–78) 71 (62–79) 0.5
Gender 116 (51.3%) 121 (53.5%) 0.6
Confusion 40 (17.7%) 41 (18.1%) 0.9
Respiratory rate 30 (20–32) 30 (20–33) 0.7
SBP 108 (91–129) 108 (90–130) 0.9
Temperature 38 (37–38.4) 38 (37–38.4) 0.9
Pulse 105 (90–120) 105 (90–120) 0.7
H+ 38 (34–43.7) 38 (34–43) 0.4
Urea 8.2 (6.4–11.7) 8.5 (6.7–11.9) 0.4
Sodium 136 (133–138) 136 (133–138) 0.8
Glucose 6.6 (5.7–8.0) 6.9 (5.7–8.5) 0.2
CRP 231 (102–339) 209 (94–352) 0.7
WCC 15.3 (11.5–20.0) 15.1 (10.1–19.4) 0.6
Albumin 36 (32–39) 36 (33–40) 0.5
CURB-65 3 (2–3) 3 (2–3) 0.1
  1. Data are median IQR except gender, which is presented as n (%)
  2. SBP systolic blood pressure, CRP C-reactive protein, WCC, white cell count, IV intravenous, IQR interquartile range